tiprankstipranks

Mark Stejbach Insider Profile

4 Followers
Mark Stejbach, Director at Indivior, holds 27.09K shares in Indivior (Ticker: INDV), holds 0.00 shares in Flexion Therapeutics (Ticker: ~FLXN), holds 51.06K shares in Alkermes (Ticker: ALKS).
tipranks
Mark Stejbach

Mark Stejbach
Indivior (INDV)
Director

Ranked #27,118 out of 108,921 Corporate Insiders

Profitable Transactions

67%
2 out of 3 Profitable Transactions

Average Return

+26.80%
Average return per transaction
Time Frame
1 Year
Compare to
No Benchmark

Insider Holdings

$3M
71.33%
28.67%
A breakdown of Mark Stejbach's holdings

Insider Roles

Alkermes
(ALKS)
SVP/Chief Comm Off, Alks Inc
Indivior
(INDV)
Director
Roles that Mark Stejbach holds in companies

Most Profitable Insider Trade

Stock:
Flexion Therapeutics
(~FLXN)
Rating:Informative Buy
Date:Jun 20, 2017 - Jun 20, 2018
Return:+55.60%
The most profitable trade made by Mark Stejbach

Mark Stejbach's Trading History

Company Name
Last Transaction Date
Insider Position
Last Transaction
Last Transaction Amount
Holding Value
Indivior
May 14, 2026
Director
Uninformative Buy
$946.42K
Alkermes
Mar 05, 2018
SVP/Chief Comm Off, Alks Inc
Uninformative Buy
261.21K
$2.35M
~FLXN
Flexion Therapeutics
Nov 19, 2021
Uninformative Sell
107.36K
$0.00
List of latest transactions for each holding click on a transaction to see Mark Stejbach's performance on stock

Mark Stejbach insider profile FAQ

What is the percentage of profitable transactions made by Mark Stejbach?
The percentage of profitable transactions made by Mark Stejbach is 67%.
    What is the average return per transaction made by Mark Stejbach?
    The average return per transaction made by Mark Stejbach is 26.80%.
      What stocks does Mark Stejbach hold?
      Mark Stejbach holds: INDV, ALKS, ~FLXN stocks.
        What was Mark Stejbach’s latest transaction?
        Mark Stejbach latest transaction was an Uninformative Buy of ―.
          What was Mark Stejbach's most profitable transaction?
          Mark Stejbach’s most profitable transaction was an Informative Buy of ~FLXN stock on June 20, 2017. The return on the trade was 55.60%.
            What is Mark Stejbach's role in Indivior?
            Mark Stejbach's role in Indivior is Director.
              How can I follow the stock ratings of top corporate insiders?
              Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.